Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CLRI","financials")Full statements spill as a table. For one cell: =jivedata("CLRI","Revenue") or =jivedata("CLRI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CLRI • CIK 0001362516
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $2,131.955 | $3,126.148 | $4,103.388 | $4,723.141 |
| Cost of Revenue | $316.163 | $866.402 | $893.466 | $950.821 |
| Gross Profit | $1,815.792 | $2,259.746 | $3,209.922 | $3,772.32 |
| Other Nonoperating Income (Expense) | $2.607 | $28.462 | $33.836 | $45.445 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $56.556 | $-272.125 | $-154.219 | $307.674 |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 |
| Dividends, Preferred Stock, Stock | $41.038 | $41.148 | $41.036 | $41.037 |
| Net Income (Loss) Available to Common Stockholders, Basic | $15.518 | $-313.273 | $-195.255 | $266.637 |
| Weighted Average Number of Shares Outstanding, Basic | 228,786,339 | 229,160,695 | 229,238,304 | 229,316,126 |
| Weighted Average Number of Shares Outstanding, Diluted | 599,107,974 | 229,160,695 | 229,238,304 | 599,637,761 |
| Selling Expense | $425.498 | $287.676 | $341.226 | $290.13 |
| General and Administrative Expense | $1,303.98 | $2,074.139 | $3,026.904 | $3,193.878 |
| Depreciation | $5.051 | $9.496 | $21.847 | $22.083 |
| Research and Development Expense | $27.314 | $189.022 | $8 | $4 |
| Operating Expenses | $1,761.843 | $2,560.333 | $3,397.977 | $3,510.091 |
| Gain (Loss) Related to Litigation Settlement | $47.792 | $42.941 | $42.941 | $42.941 |
| Interest Income (Expense), Net | $2.607 | $44.412 | $33.836 | $45.445 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Assets | $1,299.802 | $1,299.289 | $1,606.538 | $1,397.648 |
| Liabilities | $1,294.625 | $1,501.72 | $1,963.188 | $1,420.484 |
| Common Stock, Value, Issued | $2.291 | $2.291 | $2.291 | $2.291 |
| Additional Paid in Capital | $15,240.104 | $15,240.104 | $15,240.104 | $15,240.104 |
| Retained Earnings (Accumulated Deficit) | $-15,237.292 | $-15,444.9 | $-15,599.119 | $-15,265.305 |
| Stockholders' Equity Attributable to Parent | $5.177 | $-202.431 | $-356.65 | $-22.836 |
| Cash and Cash Equivalents, at Carrying Value | $516.955 | $849.727 | $1,124.052 | $1,007.158 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $545.573 | $230.686 | $208.233 | $145.691 |
| Inventory, Net | $21.913 | $41.532 | $103.524 | $65.613 |
| Prepaid Expense and Other Assets, Current | $68.522 | $82.196 | $94.101 | $110.797 |
| Assets, Current | $1,155.687 | $1,204.141 | $1,529.91 | $1,329.259 |
| Property, Plant and Equipment, Net | $16.526 | $40.832 | $38.295 | $37.556 |
| Operating Lease, Right-of-Use Asset | $29.914 | $5.983 | $5.983 | $5.983 |
| Accounts Payable and Accrued Liabilities, Current | $85.858 | $121.889 | $171.877 | $127.145 |
| Deferred Revenue, Current | $1,105.58 | $1,373.325 | $1,791.311 | $1,293.339 |
| Operating Lease, Liability, Current | $24.58 | $6.506 | $6.506 | $6.506 |
| Accounts Receivable, Allowance for Credit Loss, Current | $63.665 | $60.665 | $150.308 | $0 |
| Common Stock, Shares Authorized | 5,000,000,000 | 5,000,000,000 | 5,000,000,000 | 5,000,000,000 |
| Common Stock, Shares, Issued | — | 229,160,695 | 229,238,517 | 229,238,517 |
| Common Stock, Shares, Outstanding | 229,160,695 | 229,160,695 | 229,238,517 | 229,238,517 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|